Global healthcare regulators are implementing strict oversight protocols for artificial intelligence software intended for medical diagnostics. The regulatory shift aims to address algorithmic bias and model drift in critical clinical settings.
Validation Standards
Regulators now require continuous multi-center clinical data validation prior to granting market authorization. Static performance claims based on single-institution training sets are no longer sufficient for regulatory approval.
Liability Frameworks
Hospitals adopting diagnostic AI tools are establishing clear clinical governance frameworks. Primary legal liability remains with licensed practitioners, necessitating transparent software decision pathways.